HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovations In Taste, Convenience Drive Consumer Health Market Growth

This article was originally published in The Pink Sheet Daily

Executive Summary

Novel flavors and unique ingredients can give consumer health care marketers an edge in the marketplace, according to Datamonitor market research. Tasty products, new dosage forms and products that facilitate self-care will shape the consumer product market and drive annual 3.8% growth through 2017.

You may also be interested in...



Swedish Firm Medcoat Spreads Its Flavor Coating For Drugs, Supplements Into US

Medcoat expects burgeoning market for a product designed to make swallowing pills easier for consumers of all ages. “The age demographic has been widespread and has been a benefit to those living with many different medical conditions,” says US distribution executive Jennifer DiLascia.

Study Takes Measure Of Supplement Size And Link To Swallowing Problems

FDA and CDC Analysis of the 20,791 adverse event reports for vitamins, minerals and supplements from 2006 through 2015 found that 3,962, 19.1%, indicated swallowing problems and the 10 products most commonly identified in the reports all exceeded 17 mm, or 0.67 inch, in length.

Flonase Allergy Relief Exclusivity Sliced Up By Label Carve-Out

FDA grants Glaxo market exclusivity for OTC as the first OTC fluticasone product, but with a label carve-out that limits exclusivity to the indication of “OTC use for temporary relief of ocular symptoms due to hay fever or other upper respiratory allergies.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel